foxo4-dri peter de keizer – Longevity Med Summit Peter de Keizer on cells
Peter de Keizer on cells in hibernation Research at UMC Utrecht The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4 DRI Nature Communications Eternal youth within reach by targeting senescent cells? FOXO4 DRI: pricey, but was worth trying out in my opinion. How will I know the long term benefits? I guess I won't. See you guys when I'm 90 to report back. Senolytics: Courageous approach to fight aging and cancer
Pay in 4 interest-free payments of $6.10 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7


